Cytokinetics (CYTK) total assets

Total assets · fiscal 2025
$1.42B

Cytokinetics (CYTK) had total assets of $1.42B at the end of fiscal 2025 (December 31, 2025). That is 1.6% higher than the $1.40B of fiscal 2024. Figures as of 18 Nov 2026, 10:37 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$1.42B
Change on fiscal 2024
+1.6%
Growth, 5 years
+21.7% a year
Growth, 10 years
+28.6% a year
Highest on record
$1.42Bfiscal 2025
Lowest on record
$52.77Mfiscal 2011
Fiscal years on record
162010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Cytokinetics total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 21.7% a year; over ten years the rate was 28.6% a year. Across the 16 fiscal years on record (2010–2025), the highest was $1.42B in fiscal 2025 and the lowest $52.77M in fiscal 2011.

History · 16 fiscal years

Total assets by fiscal year

Cytokinetics total assets, year by year

Cytokinetics (CYTK) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$1.42B 1.6% up
2024$1.40B 70.0% up
2023$824.32M 18.8% down
2022$1.01B 20.6% up
2021$841.32M 57.6% up
2020$533.80M 84.2% up
2019$289.81M 37.2% up
2018$211.18M 28.4% down
2017$294.81M 73.3% up
2016$170.14M 47.6% up
2015$115.24M 13.3% down
2014$132.97M 59.8% up
2013$83.19M 7.3% up
2012$77.55M 47.0% up
2011$52.77M 32.3% down
2010$77.99M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Cytokinetics and comparable companies
CompanyTotal assetsFiscal year
Alkermes ALKS$2.49B2025
PACS Group PACS$5.58B2025
Kiniksa Pharmaceuticals International KNSA$763.63M2025
ImmunityBio IBRX$501.90M2025
Cytokinetics CYTK$1.42B2025
ABIVAX ABVX€584.34M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on CYTK

Cytokinetics, figure by figure

Cytokinetics (CYTK) overview: price, valuation and scorecardAll health care companies by market value

Cytokinetics total assets: questions and answers

How large are Cytokinetics's total assets?

Cytokinetics (CYTK) had total assets of $1.42B at the end of fiscal 2025 (December 31, 2025). That is 1.6% higher than the $1.40B of fiscal 2024.

What is the growth rate of Cytokinetics's total assets?

Over the five fiscal years to 2025 total assets grew at a compound 21.7% a year; over ten years the rate was 28.6% a year.

What are the highest and lowest total assets figures on record for Cytokinetics?

Across the 16 fiscal years on record (2010–2025), the highest was $1.42B in fiscal 2025 and the lowest $52.77M in fiscal 2011.

How is Cytokinetics's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest. For Cytokinetics it is on record here for 16 fiscal years, 2010 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Cytokinetics (CYTK) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/CYTK/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.